PREPRINT UNDER REVIEW: Nature Human Behaviour (Manuscript ID: NATHUMBEHAV-26010307, submitted Jan 17, 2026). Humans automatically attribute intentional agency to entities referred to with human pronouns ("he"/"she"), even when those entities are non-human AI systems. This linguistic cue creates three risks in safety-critical domains: (1) over-trust calibrated to human reliability rather than system performance, (2) deepfake vulnerability via undetected pronoun-identity mismatches, and (3) accountability confusion obscuring who decided and who acted in hybrid human-AI decisions. This Perspective proposes Agent Category Markers (ACMs)—compact pronouns (AE for disembodied AI, XE for embodied AI, with optional PA/PE/PH for posthuman hybrids)—predicted to suppress automatic mentalizing within the 150–420 ms neurocognitive window, trigger pragmatic incoherence detection in deepfakes (~400 ms N400 response), and stabilize responsibility attribution in incident documentation and clinical communication. ACMs integrate dual-process mentalizing models, pragmatic presuppositions about agency, and biomedical requirements for sex-as-a-biological-variable in humans (sex-differentiated; pharmacologically relevant) versus AI (strictly sex-neutral; scientifically honest). Design requirements ensure compatibility with NIST AI Risk Management Framework, ISO/IEC 42001, and FDA medical device governance. A pre-registered empirical agenda (to be registered at OSF.io) tests trust calibration, clinician override behaviour, fMRI mentalizing suppression, deepfake detection latency, accountability clarity, and conversational hazards ("I"/"you") across nine studies. Study A recruitment begins February 2026. ACMs offer minimal, deployable controls preserving human oversight, while remaining agnostic to debates about AI personhood or consciousness.
Alex Diaconu (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: